methylprednisolone and cyclophosphamide
Showing 26 - 50 of 2,306
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)
Not yet recruiting
- Primary Membranous Nephropathy
- Obinutuzumab
- Oral prednisolone and cyclophosphamide
-
Garran, Australian Capital Territory, Australia
- +12 more
Nov 1, 2023
Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)
Recruiting
- Mycophenolate Mofetil
- +2 more
- Cyclophosphamide
- Mycophenolate Mofetil
-
Changsha, Hunan, Chinathe Second Xiangya Hospital of Central South University
Aug 8, 2022
MEMBRANOUS NEPHROPATHY Trial in Madrid (TACROLIMUS, RITUXIMAB, METHYLPREDNISOLONE)
Completed
- MEMBRANOUS NEPHROPATHY
- TACROLIMUS
- +3 more
-
Madrid, SpainHospital 12 de Octubre
Jan 15, 2020
Systemic Sclerosis, Scleroderma Trial in Chicago (Rituximab, Fludarabine, Cyclophosphamide)
Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency Trial in Beijing (Plasma Exchange (PE), Methylprednisolone
Terminated
- Glomerulonephritis, IGA
- +3 more
- Plasma Exchange (PE)
- Methylprednisolone pulse
-
Beijing, Beijing, China
- +1 more
Sep 30, 2021
Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)
Not yet recruiting
- Glomerulonephritis, IGA
- Prednisolone
- Prednisolone plus Cyclophosphamide
- (no location specified)
Aug 19, 2022
Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- (no location specified)
Aug 22, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- ANCA-Associated Glomerulonephritis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Jul 23, 2023
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Jul 23, 2020
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +7 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020
Devic's Disease Trial in Chicago (Hematopoietic Stem Cell Transplantation, Cyclophosphamide, G-CSF)
Completed
- Devic's Disease
- Hematopoietic Stem Cell Transplantation
- +6 more
-
Chicago, IllinoisNorthwestern University, Feinberg School of Medicine
Feb 17, 2020
Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)
Recruiting
- Membranous Nephropathy - PLA2R Induced
- Rituximab, Cyclophosphamide, and Corticosteroids
-
Saint Petersburg, Russian FederationSt. Petersburg State Pavlov Medical University
Jan 7, 2023
Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
- R-CHOP
- R-CHOP + acalabrutinib
-
Colchester, Essex, United Kingdom
- +32 more
Oct 25, 2022
Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Cyclophosphamide
- +11 more
-
Houston, TexasM D Anderson Cancer Center
Nov 30, 2021
Henoch-Schoenlein Purpura Nephritis Trial in Nanjing (Prednisone, Cyclophosphamide(CTX), Mycophenolate mofetil(MMF))
Unknown status
- Henoch-Schoenlein Purpura Nephritis
- Prednisone
- +5 more
-
Nanjing, Jiangsu, ChinaNanjing Children's Hospital
Feb 25, 2020
Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)
Recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Modified Ponticelli regimen
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 23, 2023
Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma Trial in
Active, not recruiting
- Ann Arbor Stage IIB Hodgkin Lymphoma
- +5 more
- Bleomycin Sulfate
- +11 more
-
Birmingham, Alabama
- +198 more
Sep 16, 2022
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
GVHD, Leukemia, Lymphoma Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide, cyclosporine)
Withdrawn
- Graft Versus Host Disease
- +2 more
- anti-thymocyte globulin
- +7 more
-
Minneapolis, MinnesotaUniversity of Minnesota Cancer Center
Dec 31, 2019
Anti-Glomerular Basement Membrane Antibody Disease Trial in Worldwide (Imlifidase)
Completed
- Anti-Glomerular Basement Membrane Antibody Disease
- Imlifidase
-
Innsbruck, Austria
- +9 more
Feb 7, 2022
Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow
Recruiting
- Renal Failure
- Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
- Combined bone marrow and kidney transplant
-
Boston, MassachusettsMassachusetts General Hospital
Jan 19, 2023
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +11 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 29, 2020
Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)
Not yet recruiting
- Kidney Failure
- +2 more
- Bone Marrow Transplant
- +2 more
- (no location specified)
Jun 9, 2023